Ar therapies are developed to inhibit distinct tumor signaling pathways (84). For instance, relevant development
Ar therapies are developed to inhibit distinct tumor signaling pathways (84). For instance, relevant development issue pathways are identified to be involved in malignant glioma, such as plateletderived development factor,…